- Home
- About Us
- Services
- Resources
- Company
Quantitative Structure-Activity Relationship (QSAR) modeling is a computational method ("computer simulation") that analyzes, simulates, or predicts the toxicity of a chemical substance based on its chemical structure. At CD ComputaBio, we provide cutting-edge QSAR services that drive innovation and efficiency in drug discovery and development. Utilizing advanced computational algorithms and data analysis capabilities, our QSAR solutions enable researchers to accelerate the discovery of promising drug candidates, optimize compound libraries, and improve overall R&D efficiency.
QSAR modeling helps researchers design new drugs, predict toxicity, and assess environmental risks. Our specialized QSAR service creates mathematical models that correlate a molecule's structure with its biological activity.
Our state-of-the-art similarity search technology is designed to identify molecular structures that are similar to specific input molecules. This plays an important role in identifying new drugs, studying protein-structure interactions, and identifying off-target binding.
CD ComputaBio provides SAR services to help researchers understand and analyze the relationship between the structure of a chemical or three-dimensional biomolecule and its biological activity.
QSPR is a variant of QSAR used to predict molecular properties other than biological activity. At CD ComputaBio, our QSPR service enables researchers to predict a variety of physical properties that are critical in the drug discovery process.
CD ComputaBio's QSAR service is based on a sophisticated algorithmic framework that includes:
We utilize advanced supervised and unsupervised machine learning algorithms to develop predictive QSAR models, including Support Vector Machines (SVMs), Random Forests, Neural Networks, and Deep Learning architectures.
Our experts utilize a variety of cheminformatics software and libraries to extract molecular descriptors, analyze chemical structures, and perform data preprocessing for QSAR model development.
Rigorous statistical analysis is the foundation of our QSAR modeling, including feature selection, cross-validation, model evaluation, and identification of key structure-activity relationships.
CD ComputaBio's QSAR service has broad applicability in the pharmaceutical and biotechnology fields, with key applications including but not limited to
We understand that high-quality data is paramount for the success of QSAR modeling. To engage with our QSAR services, clients are encouraged to provide the following sample requirements:
| Sample Requirements | Descriptions |
| Chemical Structures | Accurate 2D/3D chemical structures of the compounds under investigation, preferably in formats compatible with common chemoinformatics software. |
| Biological Activity Data | Experimental or literature-derived biological activity data, such as IC50, EC50, Ki, or other relevant potency measurements, along with associated assay conditions. |
| Physicochemical Properties | When available, supplemental physicochemical properties of the compounds, such as solubility, lipophilicity, and molecular weight, enhance the robustness of QSAR modeling. |
Upon completion of the partnership with CD ComputaBio, clients can expect comprehensive deliverables, including:
| Deliverables | Descriptions |
| Comprehensive QSAR Models | Customers have access to validated QSAR models that accurately predict the biological activity and properties of compounds, enabling informed decision-making in the drug discovery process. |
| Insight into Structure-Activity Relationships | Our QSAR analyses provide valuable insight into the structural features that drive a molecule's biological activity, enabling the rational design of optimized drug candidates. |
| Data Analysis and Visualization Reports | CD ComputaBio provides detailed reports summarizing QSAR analyses, including data visualizations, statistical evaluations, and in-depth explanations of the resulting models, ensuring a transparent and clear analysis process. |
CD ComputaBio has extensive expertise in cheminformatics and computational biology to provide powerful quantitative structure-activity relationship services. We pride ourselves on our ability to provide highly predictive QSAR models that benefit the early stages of drug discovery and other chemical product development processes. Contact us today to learn more about our service information.